Fecal microbiota transplantation in recurrent Clostridium difficile infection: the first prospective study of 30 patients in Romania

Open access

Abstract

Introduction: The infection with Clostridium difficile has increased in incidence worldwide and it raises many problems with regard to therapy, resistance to treatment and especially recurrence. Recurrence is frequent in patients treated for Clostridium difficile infection, requiring vancomycin by mouth, with limited alternatives. The literature shows that one of the most efficient treatment methods in Clostridium difficile infection is the transplantation of gut microbiota, also known as fecal microbiota transplantation. Aim: We present our results following FMT performed in patients with recurrent Clostridium difficile infection, and propose a simple and effective protocol for fecal microbiota transplantation. Study design: The study was prospective. The phases of the FMT procedure: assessment of patient eligibility, patient’s consent, identification and screening of donors, discontinuation of antibiotics (vancomycin, metronidazole) 3 days prior to the procedure. Methods: Between 2013 and 2015, FMT was performed in 30 patients with recurrent Clostridium difficile infection, by direct infusion of extensively processed donor fecal matter via colonoscopy. We followed up the patients for 12 months. Results: Immediate post-transplantation outcome in what concerns stool frequency during the follow-up period (7 days) was encouraging in 93.33% of patients. The donors were healthy individuals (53% 1st degree relatives), previously screened for possible infections and infestations. This result was sustained at 6-month and 12-month follow-up. Post-transplantation recurrence occurred in 6.67% (2 patients), which responded well to treatment and did not require a new vancomycin course. Conclusions: Fecal microbiota transplantation via colonoscopy is effective, safe, easy to perform, it yields lasting results and is therefore a good option for recurrent or treatment-resistant Clostridium difficile infection.

1. Bartlett JG. Clinical practice. Antibiotic associated diarrhea. N Engl J Med. 2002 Jan;346(5):334-9. DOI: 10.1056/NEJMcp011603

2. McFarland LV. Renewed interest in a difficult disease: Clostridium difficile infections - epidemiology andcurrent treatment strategies. Curr Opin Gastroenterol. 2009 Jan;25(1):24-35. DOI: 10.1097/MOG.0b013e-32831da7c4

3. Epuran S, Rusu E, Sbarcea A, Musat S. Clostridium difficile - etiology and epidemiology. Revista romana de boli infectioase 2014;1:28-30

4. Bauer MP, Notermans DW, van Benthem BH, Brazier JS, Wilcox MH, Rupnik M, et al. Clostridium difficile infection in Europe: a hospital based survey. Lancet. 2011 Jan;377(9759):63-73. DOI: 10.1016/S0140-6736(10)61266-4

5. Lee YC, Wang JT, Chen AC, Sheng WH, Chang SC, Chen YC. Changing incidence and clinical manifestations of Clostridium difficile-associated diarrhea detected by combination of glutamate dehydrogenase and toxin assay in Northern Taiwan. J Microbiol Immunol Infect. 2012 Aug;45(4):287-95. DOI: 10.1016/j.jmii.2011.12.001

6. Ray A, Smith R, Breaux J. Fecal microbiota transplantation for Clostridium Difficile infection: The Ochsner Experience. Ochsner J. 2014 Winter; 14(4): 538-44.

7. Bakken JS. Fecal bacteriotherapy for recurrent Clostridium difficile infection. Anaerobe 2009; 15:285. DOI: 10.1016/j.anaerobe.2009.09.007

8. Rubin TA, Gessert CE, Aas J, Bakken JS. Fecal microbiome transplantation for recurrent Clostridium difficile infection: report on a case series. Anaerobe. 2013 Feb;19:22-6. DOI: 10.1016/j.anaerobe.2012.11.004

9. Grehan MJ, Borody TJ, Leis SM, Campbell J, Mitchell H, Wettstein A. Durable alteration of the colonic microbiota by the administration of donor fecal flora. J Clin Gastroenterol. 2010 Sep;44(8):551-61. DOI: 10.1097/MCG.0b013e3181e5d06b

10. Brandt LJ, Reddy SS. Fecal microbiota transplantation for recurrent Clostridium difficile infection. J Clin Gastroenterol. 2011 Nov;45 Suppl:S159-67. DOI: 10.1097/MCG.0b013e318222e603

11. Bang BW, Park JS, Kim HK, Shin YW, Kwon KS, Kwon HY, et al. Fecal Microbiota Transplantation for Refractory and Recurrent Clostridium difficile Infection: A Case Series of Nine Patients. Korean J Gastroenterol. 2017 Apr 25;69(4):226-31. DOI: 10.4166/kjg.2017.69.4.226

12. Gough E, Shaikh H, Manges AR. Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clin Infect Dis. 2011 Nov;53(10):994-1002. DOI: 10.1093/cid/cir632

13. Michael B. Edmond. The power of poop: Fecal microbiota transplantation for Clostridium Difficile infection. Trans Am Clin Climatol Assoc. 2016; 127: 71-80.

14. Konturek PC, Koziel J, Dieterich W, et al. Successful therapy of Clostridium difficile infection with fecal microbiota transplantation. J Physiol Pharmacol. 2016 Dec;67(6):859-66.

15. Eyre DW, Walker AS, Wyllie D, Dingle KE, Griffiths D, Finney J, et al. Predictors of First Recurrence of Clostridium difficile Infection: Implications for Initial Management. Clin Infect Dis. 2012 Aug; 55(2): S77-S87. DOI: 10.1093/cid/cis356

16. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, et al. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013 Apr;108(4):478-98. DOI: 10.1038/ajg.2013.4

17. Boyle ML, Ruth-Sahd LA, Zhou Z. Fecal Microbiota Transplant to Treat Recurrent Clostridium difficile Infections. Crit Care Nurse. 2015 Apr;35(2):51-64. DOI: 10.4037/ccn2015356

18. Guo B, Harstall C, Louie T, Veldhuyzen van Zanten S, Dieleman LA. Systematic review: faecal transplantation for the treatment of Clostridium difficile-associated disease. Aliment Pharmacol Ther. 2012 Apr;35(8):865-75. DOI: 10.1111/j.1365-2036.2012.05033.x

19. Cohen SH, Gerding DN, Johnson S, Kelly CP, Loo VG, McDonald LC, et al. Clinical practice guidelines for Clostridium difficile infection in adults: 2010 update by the Society for Health Epidemiology of America (SHEA) and the Infectious Diseases Society of America. Infect Control Hosp Epidemiol. 2010 May;31(5):431-55. DOI: 10.1086/651706

20. Festi D, Schiumerini R, Birtolo C, Marzi L, Montrone L, Scaioli E, et al. Gut microbiota and its pathophysiology in disease paradigms. Dig Dis. 2011;29(6):518-24. DOI: 10.1159/000332975

21. Brandt LJ, Aroniadis OC, Mellow M, Kanatzar A, Kelly C, Park T, et al. Long-term follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol. 2012 Jul;107(7):1079-87. DOI: 10.1038/ajg.2012.60

22. Mattila E, Uusitalo-Seppala R, Wuorela M, Lehtola L, Nurmi H, Ristikankare M et al. Fecal transplantation, through colonoscopy, is effective therapy for recurrent Clostridium difficile infection. Gastroenterology. 2012 Mar;142(3):490-6. DOI: 10.1053/j.gastro.2011.11.037

23. Aas J, Gessert CE, Bakken JS. Recurrent Clostridium difficile colitis: aseries involving 18 patients treated with donor stool administered via a nasogastric tube. Clin Infect Dis. 2003 Mar;36(5):580-5. DOI: 10.1086/367657

24. Rao K, Safdar N. Fecal microbiota for the treatment of Clostridium Difficile infection. J Hosp Med. 2016 Jan;11(1):56-61. DOI: 10.1002/jhm.2449

25. Gupta A, Khanna S. Fecal microbiota transplantation. JAMA. 2017 July;318(1):102. DOI: 10.1001/jama.2017.6466

Revista Romana de Medicina de Laborator

Romanian Journal of Laboratory Medicine

Journal Information


IMPACT FACTOR 2018: 0,800
5-year IMPACT FACTOR: 0,655



CiteScore 2017: 0.31

SCImago Journal Rank (SJR) 2018: 0.194
Source Normalized Impact per Paper (SNIP) 2018: 0.306

Metrics

All Time Past Year Past 30 Days
Abstract Views 0 0 0
Full Text Views 236 156 9
PDF Downloads 117 90 4